Surgery Partners
SGRY
13.71
+0.30
+2.24%
Surgery Partners
US · SGRY
#2884 by market cap
Listed 2015
13.71
+0.30
+2.24%
Live - 5344 symbols - heartbeat 226s ago
· 2026-10-08 07:31
Pre-market
14.30
+4.30%
After-hours
13.71
0.00%
- Market cap
- 1.79B
- P/E (TTM)i
- -19.87
- P/Bi
- 1.07
- EPSi
- -0.61
- Div yieldi
- 0.00%
- 52W posi
- 19%
Reader sentiment
Are you bullish or bearish on SGRY?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 9 analysts
Buy
Avg price target
18.50 +34.9%
Price target rangecurrent 13.71
Low14.00
Avg18.50
High24.00
Buy 67%
Hold 33%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-29 | RBC Capital | -- | BUY | 19.00 |
| 2026-09-18 | TD Cowen | -- | BUY | 19.00 |
| 2026-09-18 | BofA Securities | -- | BUY | 20.00 |
| 2026-09-17 | TD Cowen | -- | BUY | 19.00 |
| 2026-09-14 | J.P. Morgan | -- | HOLD | 15.00 |
| 2026-08-28 | Barclays | -- | HOLD | 14.00 |
| 2026-08-11 | TD Cowen | -- | BUY | 19.00 |
| 2026-08-11 | StoneX | -- | BUY | 24.00 |
| 2026-08-11 | KeyBanc | -- | HOLD | -- |
| 2026-08-10 | Cantor Fitzgerald | -- | BUY | 18.00 |
| 2026-08-10 | RBC Capital | -- | BUY | 19.00 |
| 2026-07-13 | Mizuho Securities | -- | BUY | 19.00 |
| 2026-05-14 | BofA Securities | -- | BUY | 17.50 |
| 2026-05-12 | Barclays | -- | HOLD | 14.00 |
| 2026-05-12 | RBC Capital | -- | BUY | 20.00 |
| 2026-05-06 | KeyBanc | -- | HOLD | -- |
| 2026-05-06 | Jefferies | -- | BUY | 17.00 |
| 2026-05-05 | TD Cowen | -- | BUY | 20.00 |
| 2026-04-20 | Jefferies | -- | BUY | 15.00 |
| 2026-03-27 | J.P. Morgan | -- | HOLD | 14.00 |
| 2026-03-10 | UBS | -- | BUY | 21.00 |
| 2026-03-05 | TD Cowen | -- | BUY | 20.00 |
| 2026-03-05 | UBS | -- | BUY | 21.00 |
| 2026-03-05 | Mizuho Securities | -- | BUY | 17.00 |
| 2026-03-05 | Jefferies | -- | BUY | 16.25 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-10 | -- | ±12.56% | +2.70% (in line) |
| 2026/Q1 | 2026-05-05 | -- | ±16.20% | +0.42% (in line) |
| 2025/Q4 | 2026-03-02 | After close | ±14.64% | -12.34% (in line) |
| 2025/Q3 | 2025-11-10 | -- | ±9.65% | -25.42% (beat) |
| 2025/Q2 | 2025-08-05 | -- | ±10.26% | -0.34% (in line) |
| 2025/Q1 | 2025-05-12 | -- | ±10.99% | +4.96% (in line) |
| 2024/Q4 | 2025-03-03 | -- | ±13.41% | -0.33% (in line) |
| 2024/Q3 | 2024-11-12 | -- | ±18.97% | -5.92% (in line) |
| 2024/Q2 | 2024-08-06 | -- | ±14.43% | +3.20% (in line) |
| 2024/Q1 | 2024-05-07 | -- | ±14.91% | +8.48% (in line) |
| 2023/Q4 | 2024-02-26 | -- | ±15.51% | -8.60% (in line) |
| 2023/Q3 | 2023-11-07 | -- | ±12.43% | +13.99% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:31:14 · For reference only, not investment advice and not tailored to your situation.